A Study of TQ05105 in Patients With Chronic Graft Versus Host Disease
Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
This study was a single arm, open label, multicenter phase Ib / II trial in subjects with
glucocorticoid refractory / dependent moderate to severe cGVHD.The trial consisted of two
phases: phase I for the dose exploration and phase II for the extension study.